Lifestyle, dietary, and behavioral determinants of lower urinary tract symptoms (luts): integrating clinical evidence with digital health and emerging technologies
Abstract
Lower urinary tract symptoms (LUTS) are highly prevalent and multifactorial conditions that significantly impair quality of life and contribute to substantial healthcare burden. Their etiology involves complex interactions between physiological, behavioral, and environmental factors.
This narrative review aims to synthesize current evidence on the role of lifestyle, dietary, social, and behavioral determinants in the prevention and management of LUTS. A structured literature search was conducted using PubMed, Scopus, and Web of Science, including observational studies, randomized controlled trials, and recent systematic reviews.
The available evidence indicates that modifiable factors such as obesity, physical inactivity, smoking, and dietary habits play a significant role in the development and progression of LUTS. Fluid intake patterns, caffeine and alcohol consumption, and overall dietary composition influence symptom severity, particularly storage symptoms. In addition, psychosocial determinants—including stress, socioeconomic status, and health literacy—affect symptom perception, healthcare-seeking behavior, and treatment adherence.
Recent advances in digital health and artificial intelligence offer new opportunities for improving LUTS management through real-time monitoring, personalized interventions, and data-driven clinical decision-making.
In conclusion, LUTS management should adopt a multidisciplinary and patient-centered approach integrating lifestyle…
Read the paper
Related studies
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
- Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
- Luteolin Inhibits Dexamethasone‐Induced Osteoporosis by Autophagy Activation Through miR‐125b‐5p/SIRT3/AMPK/mTOR Axis, an In Vitro and In Vivo Study
- Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
- Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023
- Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.